A modified thymosin alpha 1 inhibits the growth of breast cancer both in vitro and in vivo: suppressment of cell proliferation, inducible cell apoptosis and enhancement of targeted anticancer effects.
about
Replication Study: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugsThymosin α-1 does not correct F508del-CFTR in cystic fibrosis airway epithelia.Thymosin α1 treatment reduces hepatic inflammation and inhibits hepatocyte apoptosis in rats with acute liver failure.
P2860
A modified thymosin alpha 1 inhibits the growth of breast cancer both in vitro and in vivo: suppressment of cell proliferation, inducible cell apoptosis and enhancement of targeted anticancer effects.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A modified thymosin alpha 1 in ...... f targeted anticancer effects.
@en
type
label
A modified thymosin alpha 1 in ...... f targeted anticancer effects.
@en
prefLabel
A modified thymosin alpha 1 in ...... f targeted anticancer effects.
@en
P2093
P2860
P1433
P1476
A modified thymosin alpha 1 in ...... f targeted anticancer effects.
@en
P2093
Heng Zheng
Tingting Yu
Xiangdong Gao
Xingzhen Lao
P2860
P2888
P304
P356
10.1007/S10495-015-1151-Z
P577
2015-08-18T00:00:00Z